Posttransplant Lymphoproliferative Disorder
2 clinical trials · Condition
◉ Watch Posttransplant Lymphoproliferative Disorder
| Record | Firm | Date |
|---|---|---|
| Risk-stratified Sequential Treatment of Post-transplant Lymphoproliferative Disease (PTLD) With Rituximab SC and Immunochemotherapy (NCT02042391) | Diako Ev. Diakonie-Krankenhaus gemeinnützige GmbH | 2015-02-03 |
| Risk Stratified Sequential Treatment for CD20-positive PTLD (NCT00590447) | Charite University, Berlin, Germany | 2006-12-01 |
Track Posttransplant Lymphoproliferative Disorder automatically
Every clearance here is in the API, with alerts when new ones post.